{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:26:52Z","timestamp":1790659612059,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jaip.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T08:00:23Z","timestamp":1422518423000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis"],"prefix":"10.1016","volume":"3","author":[{"given":"Astrid L.","family":"Voskamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Symons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn E.","family":"O'Hehir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo A.","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2014.12.008_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"Rosenberg","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2500\/108854194778816463","article-title":"Diagnosis and management of allergic bronchopulmonary aspergillosis","volume":"15","author":"Greenberger","year":"1994","journal-title":"Allergy Proc"},{"key":"10.1016\/j.jaip.2014.12.008_bib3","series-title":"Middleton's Allergy Principles and Practice","first-page":"1000","article-title":"Allergic bronchopulmonary aspergillosis and hypersensitivity pneumonitis","author":"Douglass","year":"2013"},{"key":"10.1016\/j.jaip.2014.12.008_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A\u00a0randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mai.2003.1388","article-title":"Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial","volume":"111","author":"Wark","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib6","first-page":"138","article-title":"The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk","volume":"117","author":"Schwartz","year":"1991","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib7","unstructured":"Global Strategy for Asthma Management and Prevention. GINA 2011. http:\/\/www.ginasthma.org\/.\u00a0Accessed 2011."},{"key":"10.1016\/j.jaip.2014.12.008_bib8","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.rmed.2010.07.011","article-title":"Omalizumab-induced decrease of FcxiRI expression in patients with severe allergic asthma","volume":"104","author":"Chanez","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2004.00770.x","article-title":"The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma","volume":"60","author":"Bousquet","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1185\/030079903125002171","article-title":"Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma","volume":"19","author":"Hochhaus","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2014.12.008_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/thx.2004.035519","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody","volume":"62","author":"van der Ent","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2014.12.008_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/02770903.2010.491144","article-title":"Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab","volume":"47","author":"Lin","year":"2010","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2014.12.008_bib15","first-page":"145","article-title":"A\u00a0case of allergic bronchopulmonary aspergillosis treated with omalizumab","volume":"22","author":"Sastre","year":"2012","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/JAA.S34579","article-title":"Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab","volume":"5","author":"Collins","year":"2012","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1579-2129(09)71023-7","article-title":"Effective anti-immunoglobulin-E antibody treatment of a patient with allergic bronchopulmonary aspergillosis","volume":"45","author":"Quintas Vazquez","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jaip.2014.12.008_bib18","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1398-9995.2011.02599.x","article-title":"Allergic bronchopulmonary aspergillosis and omalizumab","volume":"66","author":"Tillie-Leblond","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2010.153312","article-title":"Effects of omalizumab in Aspergillus-associated airway disease","volume":"66","author":"Perez-de-Llano","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2014.12.008_bib20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1183\/09031936.00139513","article-title":"Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2014.12.008_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0091-6749(91)90094-5","article-title":"Monitoring human basophil activation via CD63 monoclonal antibody 435","volume":"88","author":"Knol","year":"1991","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1398-9995.2005.00870.x","article-title":"Passive IgE-sensitization by blood transfusion","volume":"60","author":"Johansson","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1398-9995.2006.00987.x","article-title":"Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation","volume":"61","author":"Nopp","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1398-9995.2008.01900.x","article-title":"CD-sens: a biological measure of immunological changes stimulated by ASIT","volume":"64","author":"Nopp","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaci.2009.09.012","article-title":"Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge","volume":"125","author":"Eckman","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.7326\/0003-4819-96-3-286","article-title":"Allergic bronchopulmonary aspergillosis: staging as an aid to management","volume":"96","author":"Patterson","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/archinte.1986.00360170130020","article-title":"Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies","volume":"146","author":"Patterson","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib28","first-page":"29","article-title":"Standardization of Spirometry, 1994 Update","volume":"152","author":"Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0895-4356(92)90095-5","article-title":"A\u00a0scale for the measurement of quality of life in adults with asthma","volume":"45","author":"Marks","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jaip.2014.12.008_bib31","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.4049\/jimmunol.173.9.5872","article-title":"Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity","volume":"173","author":"Drew","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib32","first-page":"356","article-title":"Pharmacokinetics\/dynamics following administration of a recombinant humanized monoclonal anti IgE antibody in the cynomolgus monkey","volume":"95","author":"Schoenhoff","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0091-6749(86)80106-3","article-title":"The concept of basophil releasability","volume":"77","author":"Lichtenstein","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.12.008_bib34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.22937","article-title":"Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence","volume":"49","author":"Tanou","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2014.12.008_bib37","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis","author":"Homma","year":"2013","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.jaip.2014.12.008_bib38","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2014.12.008_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MCP.0b013e32833e24a6","article-title":"Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis","volume":"16","author":"Moss","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1398-9995.2009.02147.x","article-title":"Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis","volume":"65","author":"Brinkmann","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.12.008_bib41","first-page":"CD003559","article-title":"Anti-IgE for chronic asthma in adults and children","author":"Walker","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2014.12.008_bib42","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1164\/rccm.201001-0087OC","article-title":"IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma","volume":"182","author":"Fairs","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","article-title":"Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study","volume":"179","author":"Denning","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2014.12.008_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jaci.2011.01.022","article-title":"Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma","volume":"127","author":"Andersson","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814006436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814006436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:09:04Z","timestamp":1761973744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219814006436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2213219814006436"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2014.12.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}